Trv Gp Ii, LLC Sage Therapeutics, Inc. Transaction History

Trv Gp Ii, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 03, 2019	SELL	$89.33 - $163.65 $3.34 Million - $6.11 Million	-37,362 Closed	0 $0
Q1 2018 Apr 19, 2018	SELL	$152.15 - $192.33 $77.7 Million - $98.2 Million	-510,554 Reduced 93.18%	37,362 $6.02 Million
Q4 2017 Feb 13, 2018	BUY	$60.72 - $167.34 $33.3 Million - $91.7 Million	547,916	547,916 $90.2 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Trv Gp Ii, LLC, based on Form 13F filings with the SEC.

Stay updated on Trv Gp Ii, LLC with notifications on news.